TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
GLAS

Glass House Brands Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

5.10$ -0.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GLAS
Line item Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
55.2% 45.2% 69.4% 66.0% 75.3% 66.5% 69.2%
44.8% 54.8% 30.6% 34.0% 24.7% 33.5% 30.8%
38.9% 26.1% 49.8% 56.3% 50.2% 32.6% 46.5%
102.7% 78.4% 129.6% 132.6% 135.4% 106.4% 125.1%
-2.7% 21.6% -29.6% -32.6% -35.4% -6.4% -25.1%
5.1% 4.0% 4.7% 2.7% 3.2% 1.3% 2.9%
-15.8% 25.1% -28.9% -32.3% -34.4% -3.2% -23.7%
-22.3% 18.2% -32.0% -41.1% -42.3% -14.5% -31.7%
– 37.3% -13.8% -19.2% -21.3% 6.2% -11.2%

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?